-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Guardant Health, Raises Price Target to $190

Benzinga·07/01/2026 16:48:58
Listen to the news
BTIG analyst Mark Massaro maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $160 to $190.